07:00 , Aug 21, 2006 |  BC Week In Review  |  Company News

Altus management update

Altus Pharmaceuticals Inc. (ALTU), Cambridge, Mass.   Business: Gastrointestinal, Endocrine, Metabolic   Hired: Renato Fuchs as SVP of manufacturing and technical operations, formerly SVP of manufacturing and operations at Shire Pharmaceuticals Group plc; and John...
07:00 , Aug 14, 2006 |  BC Week In Review  |  Company News

Altus management update

Altus Pharmaceuticals Inc. (ALTU), Cambridge, Mass.   Business: Gastrointestinal, Endocrine, Metabolic   Hired: John Sorvillo as VP of business development, formerly CEO at Bionaut Pharmaceuticals Inc.  ...
07:00 , May 23, 2005 |  BC Week In Review  |  Company News

Bionaut, National Cancer Institute deal

The parties will collaborate to profile Bionaut's cancer compounds that inhibit the ability of tumors cells to survive under stress conditions. Also, NCI will test Bionaut's compounds against a panel of tumor cell lines and...
07:00 , Apr 18, 2005 |  BC Week In Review  |  Company News

AnalytiCon, Bionaut deal

The companies partnered to identify and optimize compounds that inhibit the ability of tumor cells to survive under stress conditions. Bionaut will provide compounds, and AnalytiCon will use its natural product and medicinal chemistry capabilities...
01:24 , Apr 15, 2005 |  BC Extra  |  Company News

Bionaut, AnalytiCon in cancer deal

Bionaut (Cambridge, Mass.) and AnalytiCon Discovery (Potsdam, Germany) partnered to identify and optimize cancer compounds. Bionaut will provide compounds that have shown in vivo activity in human tumor xenograft models and will validate the compounds...
07:00 , Jul 12, 2004 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Bionaut Pharmaceuticals Inc. Cambridge, Mass. Technology: Cell-based reporter assay platform Disease focus: Cancer and inflammation Clinical status: Preclinical Founded: 2000 by Mehran Khodadoust and Thomas Klein Corporate partners: AstraZeneca plc ; Biogen Idec Inc. ;...
07:00 , Jul 12, 2004 |  BioCentury  |  Emerging Company Profile

Bionaut: Fast track pathways

By employing a pathway-based approach to drug discovery, with a focus on cancer and inflammation, Bionaut Pharmaceuticals Inc. hopes to avoid the dead ends that have plagued conventional target-based methods. The company will soon enter...
07:00 , Jul 14, 2003 |  BC Week In Review  |  Company News

Bionaut management update

Bionaut Pharmaceuticals Inc. , Cambridge, Mass.   Business: Cancer, Autoimmune/Inflammation   Hired: Kees Been as CEO, formerly SVP of the oncology business unit at Biogen Inc.  ...
07:00 , Jul 8, 2003 |  BC Extra  |  Company News

Bionaut names Been CEO

Bionaut (Cambridge, Mass.) hired Kees Been as CEO. Prior, he was VP of the oncology business unit at Biogen (BGEN). Bionaut is developing therapeutics for cancer and inflammation using its Sentinel Pathway Reporter System technology....